+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Repurposing host-based therapeutics to control coronavirus and influenza virus



Repurposing host-based therapeutics to control coronavirus and influenza virus



Drug Discovery Today 24(3): 726-736



The development of highly effective antiviral agents has been a major objective in virology and pharmaceutics. Drug repositioning has emerged as a cost-effective and time-efficient alternative approach to traditional drug discovery and development. This new shift focuses on the repurposing of clinically approved drugs and promising preclinical drug candidates for the therapeutic development of host-based antiviral agents to control diseases caused by coronavirus and influenza virus. Host-based antiviral agents target host cellular machineries essential for viral infections or innate immune responses to interfere with viral pathogenesis. This review discusses current knowledge, prospective applications and challenges in the repurposing of clinically approved and preclinically studied drugs for newly indicated antiviral therapeutics.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 066452817

Download citation: RISBibTeXText

PMID: 30711575


Related references

Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication. Assay and Drug Development Technologies 13(10): 638-649, 2015

Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics. European Journal of Cell Biology 94(7-9): 375-383, 2016

The Mechanisms for Within-Host Influenza Virus Control Affect Model-Based Assessment and Prediction of Antiviral Treatment. Viruses 9(8):, 2017

Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus. Journal of Virology 73(5): 3737-3743, 1999

Studies on host-virus interactions in the chick embryo-influenza virus system. V. Simultaneous serial passage of the agents of influenza A and B in relation to variations in the growth cycle of influenza B virus. Journal of Experimental Medicine 94(4): 291-304, 1951

Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection. Frontiers in Microbiology 6: 676, 2015

Preparation of armored RNA as a control for multiplex real-time reverse transcription-PCR detection of influenza virus and severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology 46(3): 837-841, 2008

Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?. Current Opinion in Immunology 53: 45-50, 2018

Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?. Current Opinion in Immunology 53: 45-50, 2018

Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS). Bioorganic and Medicinal Chemistry 23(17): 6036-6048, 2015

The growth cycle of influenza virus A; a study of the relations between virus, soluble antigen and host cell in fertile eggs inoculated with influenza virus. British Journal of Experimental Pathology 29(5): 390-399, 1948

Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection. F1000research 5: 190, 2016

Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clinical Infectious Diseases 58(4): 449-457, 2015

Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics. Drug Discovery Today 23(3): 503-518, 2018

Studies on host-virus interactions in the chick embryo-influenza virus system; the propagation of virus in conjunction with the host cells. Journal of Experimental Medicine 90(1): 13-22, 1949